Panacea Life Sciences Holdings, Inc. (PLSH) Free cash flow 2014–2023
Panacea Life Sciences Holdings, Inc. (PLSH) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$1.6MFY2023 · since FY2014: -$405,668 → -$1.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$1.6M | +39.9% |
| FY2022 | -$2.6M | +35.3% |
| FY2021 | -$4.1M | +62.3% |
| FY2020 | -$10.8M | -72.5% |
| FY2019 | -$6.3M | -1250.0% |
| FY2018 | -$465,755 | — |
| FY2016 | -$892,248 | -39.4% |
| FY2015 | -$640,020 | -57.8% |
| FY2014 | -$405,668 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice